10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
18.25
+0.41 (2.30%)
Dec 10, 2025, 11:22 AM EST - Market open
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $2.31 billion as of December 10, 2025. Its market cap has increased by 43.56% in one year.
Market Cap
2.31B
Enterprise Value
1.86B
1-Year Change
43.56%
Ranking
Category
Stock Price
$18.25
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $2.31B, a decrease of -53.35%. That is a compound annual growth rate of -11.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 2.26B | 29.88% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |